OBJ Limited is a drug delivery technology company that specialises in transdermal drug delivery technologies.

OBJ Limited has assembled an experienced team of medical, scientific and commercial specialists that has supported a cross-disciplinary approach and delivered elegant medical technology solutions with immediate commercial applications. OBJ Limited welcomes discussions and collaborations with pharmaceutical and cosmetic partners in the design and development of all aspects of non-invasive transdermal drug delivery.

For further information on partnering with OBJ contact:

OBJ Limited | 284 Oxford Street Leederville WA 6007 Australia
P +61 8 9443 3011 | F +61 8 9443 3866 | W www.obj.com.au

Note on Intellectual Property:

The OBJ active drug delivery system employs a propriety delivery process that is the subject of multiple interlocking patent applications in both Australia and the USA. Patent applications covering multiple aspects covering the delivery mechanisms have been lodged along with drug specific patent applications. New IP opportunities exist for specific implementations of the OBJ technical in relation to specific drugs, compounds and applications.